Nanovector-based Wellness and Environmental Solutions
Legal Citation
Summary of the Inventive Concept
This inventive concept leverages the core technology of nanovectors for delivering active substances in the body to explore new applications in personalized wellness, skin care, diagnostics, environmental monitoring, and agriculture.
Background and Problem Solved
The original patent focused on nanovectors for delivering active substances in the human body. However, there is a growing need for innovative solutions in other industries. This inventive concept addresses the limitations of current technologies in wellness, skin care, diagnostics, environmental monitoring, and agriculture by providing targeted, efficient, and personalized solutions.
Detailed Description of the Inventive Concept
The inventive concept comprises a nanovector delivery platform utilizing polysiloxane-based nanoparticles for targeted release of wellness compounds, skin-active substances, biomarkers, environmental pollutants, and plant growth-promoting substances. The nanovectors are designed to have a mean diameter of less than 10 nm, allowing for efficient delivery and uptake. The nanoparticles can be functionalized with specific ligands, chelating agents, and metal elements to enhance their properties. The system can be integrated with various sensors, monitoring systems, and data analytics tools to provide real-time feedback and personalized recommendations.
Novelty and Inventive Step
The new claims introduce novel applications of nanovectors in wellness, skin care, diagnostics, environmental monitoring, and agriculture, which were not contemplated in the original patent. The inventive step lies in the adaptation of the core technology to these new fields, enabling targeted and efficient solutions that address specific industry challenges.
Alternative Embodiments and Variations
Alternative embodiments of the inventive concept could include the use of different nanoparticle materials, varying the nanoparticle size and shape, or incorporating additional functional groups. Variations could also involve integrating the nanovector delivery platform with other technologies, such as microfluidics, artificial intelligence, or the Internet of Things (IoT).
Potential Commercial Applications and Market
The inventive concept has significant commercial potential in various industries, including wellness, skin care, diagnostics, environmental monitoring, and agriculture. The market for these solutions is expected to grow substantially in the coming years, driven by increasing demand for personalized and sustainable solutions. The inventive concept could be licensed to companies operating in these industries, or developed into proprietary products and services.
CPC Classifications
| Section | Class | Group |
|---|---|---|
| A | A61 | A61K38/31 |
| A | A61 | A61K9/146 |
| A | A61 | A61K31/704 |
| A | A61 | A61K33/243 |
| A | A61 | A61K33/244 |
| A | A61 | A61K47/6929 |
| A | A61 | A61K49/0002 |
| A | A61 | A61K49/128 |
| A | A61 | A61K49/1881 |
| A | A61 | A61P35/00 |
| B | B82 | B82Y5/00 |
| A | A61 | A61K9/0019 |
Section 103 Obviousness Analysis (PHOSITA)
Field of Art
Nanomedicine and targeted drug delivery systems, with expertise in nanoparticle design, surface functionalization, and biomedical applications involving polysiloxane-based nanostructures
Person of Ordinary Skill (PHOSITA) Profile
A researcher with advanced degrees in materials science, chemistry, or bioengineering, possessing knowledge of nanoparticle synthesis, surface modification techniques, and interdisciplinary applications of targeted delivery platforms
Obviousness Rationale
A person having ordinary skill would recognize that the core nanovector technology disclosed in US 11857604 provides a versatile platform that can be readily adapted to multiple application domains by leveraging known surface modification and functionalization techniques. The polysiloxane nanoparticle's inherent properties of small diameter, physisorption capabilities, and metal element integration naturally suggest broader applications beyond initial medical contexts. A PHOSITA would understand that targeted delivery mechanisms are fundamentally transferable across different domains such as wellness, agriculture, and environmental monitoring.
Obvious Combinations & Variations
Original Patent Information
| Patent Number | US 11,857,604 |
|---|---|
| Title | Nanovectors and uses |
| Assignee(s) | NH THERAGUIX |